SB

Syntis Bio at ObesityWeek 2026

Nov 14–17, 2026 National Harbor, MD ~4.4k attendees Website

Syntis Bio brings 2 presentations to ObesityWeek 2026 in National Harbor. Its sessions report early clinical studies of SYNT-101. They cover safety, tolerability, pharmacokinetics and pharmacodynamics in a single ascending dose study in adults and a 28-day study in adults with obesity.

OrganizationObesityWeek 2026 Attendance
SB
Syntis Bio
Boston, MA
Biotech
Develops a once-daily oral pill that temporarily coats the upper small intestine to mimic the metabolic effects of gastric bypass.
Poster
Mon Nov 16
2:30pm–3:30pm
Poster
Mon Nov 16
2:30pm–3:30pm

Explore the full ObesityWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in National Harbor. Leave your work email and we’ll be in touch.

Privacy

Download the full ObesityWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Syntis Bio

Tell us what you sell and we’ll find the people at Syntis Bio most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by The Obesity Society (TOS), ObesityWeek® or the American Society for Metabolic and Bariatric Surgery (ASMBS). Submit a correction